Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$69K Buy
+950
New +$67.1K 0.01% 522
2018
Q2
Sell
-68
Closed -$2.54K 1141
2018
Q1
$2.54K Hold
68
﹤0.01% 993
2017
Q4
$2.91K Sell
68
-338
-83% -$13.5K ﹤0.01% 991
2017
Q3
$14.9K Sell
406
-949
-70% -$38.3K ﹤0.01% 736
2017
Q2
$61.5K Sell
1,355
-9
-0.7% -$397 0.02% 514
2017
Q1
$58K Sell
1,364
-18
-1% -$734 0.02% 507
2016
Q4
$55.4K Buy
1,382
+12
+0.9% +$463 0.02% 513
2016
Q3
$53.2K Sell
1,370
-2
-0.1% -$76 0.02% 524
2016
Q2
$47.5K Sell
1,372
-400
-23% -$13.9K 0.01% 523
2016
Q1
$61.1K Buy
1,772
+96
+6% +$3.35K 0.02% 459
2015
Q4
$64.8K Buy
1,676
+426
+34% +$16.6K 0.02% 484
2015
Q3
$48.9K Hold
1,250
0.02% 521
2015
Q2
$47.6K Hold
1,250
0.01% 563
2015
Q1
$41.3K Hold
1,250
0.01% 577
2014
Q4
$33.4K Hold
1,250
0.01% 618
2014
Q3
$30.4K Hold
1,250
0.01% 660
2014
Q2
$31.7K Hold
1,250
0.01% 588
2014
Q1
$26.9K Sell
1,250
-6,500
-84% -$140K 0.01% 609
2013
Q4
$173K Buy
+7,750
New +$171K 0.06% 291

Other funds holding HOLX

Winslow Evans & Crocker's HOLX Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Hologic (HOLX) in Q4 2020: 950 shares worth $69K. The stake represents 0.01% of the portfolio and ranks #522 among its holdings. This is a return to the name: Winslow Evans & Crocker previously reported a position in HOLX as recently as Q1 2018.

Winslow Evans & Crocker first reported a position in HOLX in Q4 2013 and has held it in 19 quarters since. The position peaked at $173K in Q4 2013. 628 funds tracked by Wall St. Rank hold HOLX as of Q4 2020.

  • Winslow Evans & Crocker held 950 shares of Hologic worth $69K as of Q4 2020.
  • Hologic was a new Winslow Evans & Crocker position in Q4 2020.
  • Hologic made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #522 holding.
  • Winslow Evans & Crocker first reported a position in Hologic in Q4 2013 and has held it in 19 quarters since.
  • Winslow Evans & Crocker's Hologic position peaked at $173K in Q4 2013.
  • 628 funds tracked by Wall St. Rank held Hologic as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.